US Edition
US aid cuts halt HIV vaccine research in South Africa, with global impact
SOUTH AFRICA, JUL 13 – U.S. aid cuts removed $46 million from South Africa's HIV research, causing layoffs of 8,000 health workers and threatening progress in tuberculosis and HIV treatment.
- Earlier this month, the U.S. under President Donald Trump halted the BRILLIANT HIV vaccine project with a $46 million funding cut, just a week before trials were to begin.
- Amid U.S. under President Donald Trump’s broader foreign aid reduction, all funding for South Africa's HIV vaccine project was withdrawn, partly due to baseless claims targeting the white Afrikaner minority.
- Just a week before trials, vaccines showed immune responses, indicating readiness despite funding cuts, as noted by researchers including Glenda Gray.
- As a result of US aid cuts, about 8,000 South African health workers have been laid off, with infections expected to increase, according to sources.
- South African universities and science councils could lose about $107 million over five years, threatening the country's HIV and tuberculosis research capacity, with broader global implications.
55 Articles
55 Articles
Behind US Exit From WHO, a Battle Over Direction of Global Public Health
As the World Health Organization celebrated the adoption of a landmark pandemic treaty in May, the United States deepened its criticism of the United Nations agency—which it contends has become corrupt, beholden to special interests, and diverted from its core mission. While a U.S. delegation was absent from the 78th World Health Assembly in Geneva—where member states approved the world’s first pandemic agreement with 124 votes in favor, no obje…
U.S. aid cuts halt HIV vaccine research in South Africa, with global impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history’s deadliest pandemics. Then the email arrived.
Commentary: Trump’s foreign-aid cuts are ending lives — and US influence
The White House has hailed H.R. 1, aka the One Big Beautiful Bill Act, as a “once-in-a-generation piece of legislation” that puts “America First.” Most of the public debate focused on its extension of lower taxes for the rich, the…
US Aid Cuts Halt HIV Vaccine Research In South Africa, With Global Impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
Funding Cuts Stall Crucial HIV Research in South Africa
The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a broader cutback on foreign aid. The BRILLIANT project, integral to HIV medication development, struggles to survive, with significant consequences for global health research and employment in Africa.
Coverage Details
Bias Distribution
- 51% of the sources lean Left
To view factuality data please Upgrade to Premium
